This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Lormetazepam: Difference between revisions
Jump to navigation
Jump to search
>Follabras112 No edit summary |
>Follabras112 No edit summary |
||
| Line 1: | Line 1: | ||
<br />{{DepressantOD|benzodiazepines}}{{SummarySheet}} | |||
Lormetazepam (sold commercially as Noctamid, Sedalam, Ergocalm and others) is a short acting depressant benzodiazepine to intermediate acting 3-hydroxy benzodiazepine derivative and temazepam analogue. | Lormetazepam (sold commercially as Noctamid, Sedalam, Ergocalm and others) is a short acting depressant benzodiazepine to intermediate acting 3-hydroxy benzodiazepine derivative and temazepam analogue. | ||
It's used for the short-term treatment of moderate to severe insomnia, and to induce sleep in pre- and postoperative periods. | It's used for the short-term treatment of moderate to severe insomnia, and to induce sleep in pre- and postoperative periods. | ||
Revision as of 01:46, 17 May 2025
Fatal overdose may occur when benzodiazepines are combined with other depressants such as opiates, barbiturates, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances.[1]
It is strongly discouraged to combine these substances, particularly in common to heavy doses.
| Summary sheet: Lormetazepam |
Lormetazepam (sold commercially as Noctamid, Sedalam, Ergocalm and others) is a short acting depressant benzodiazepine to intermediate acting 3-hydroxy benzodiazepine derivative and temazepam analogue.
It's used for the short-term treatment of moderate to severe insomnia, and to induce sleep in pre- and postoperative periods.